STAT

Opinion: Should we have separated conjoined twins, knowing one would die?

If we didn't do something, Twin A would die and take Twin B with her. Did our medical team have a duty to act, or should we allow nature to…

Doctors work hard to save lives. But what if saving one life might mean ending another?

Several colleagues and I at the MassGeneral Hospital for Children recently faced that chilling and ethically daunting question. It started with a phone call on a Friday afternoon before a long weekend. As chair of our pediatric ethics committee, I’m used to calls from colleagues posing questions. But this one was different. Our hospital was being asked to evaluate 22-month-old conjoined twins to see if we could separate them.

My mind immediately turned to cases typically portrayed in the media. A massive team assembles and, after extensive planning and preparation, performs a grueling day or two of separation surgery. The children have some postoperative challenges but eventually leave the hospital healthy, a testament

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks